Literature DB >> 29153484

Translation initiation factors and their relevance in cancer.

Columba de la Parra1, Beth A Walters1, Phillip Geter1, Robert J Schneider2.   

Abstract

Deregulation of several translation initiation factors occurs in numerous types of cancers. Translation initiation factors are not merely ancillary players in cancer development and progression, but rather, they are key participants in cellular transformation and tumor development. In fact, the altered expression of translation initiation factors is involved in cancer cell survival, metastasis and tumor angiogenesis. Although the exact mechanisms remain to be fully characterized, translation initiation factors comprise novel targets for pharmacologic intervention. Here we review the most recently established roles of initiation factors in cancer development and progression, as well as unique methods used to study translational regulation.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29153484      PMCID: PMC7269109          DOI: 10.1016/j.gde.2017.11.001

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  49 in total

1.  Translation from unconventional 5' start sites drives tumour initiation.

Authors:  Ataman Sendoel; Joshua G Dunn; Edwin H Rodriguez; Shruti Naik; Nicholas C Gomez; Brian Hurwitz; John Levorse; Brian D Dill; Daniel Schramek; Henrik Molina; Jonathan S Weissman; Elaine Fuchs
Journal:  Nature       Date:  2017-01-11       Impact factor: 49.962

2.  Differential Regulation of the Melanoma Proteome by eIF4A1 and eIF4E.

Authors:  Cailin E Joyce; Adrienne G Yanez; Akihiro Mori; Akinori Yoda; Johanna S Carroll; Carl D Novina
Journal:  Cancer Res       Date:  2016-11-22       Impact factor: 12.701

3.  Eukaryotic translation initiation factor 3, subunit C is overexpressed and promotes cell proliferation in human glioma U-87 MG cells.

Authors:  Jinmin Hao; Chaohui Liang; Baohua Jiao
Journal:  Oncol Lett       Date:  2015-03-26       Impact factor: 2.967

4.  Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma.

Authors:  Christos Demosthenous; Jing Jing Han; Mary J Stenson; Matthew J Maurer; Linda E Wellik; Brian Link; Kristen Hege; Ahmet Dogan; Eduardo Sotomayor; Thomas Witzig; Mamta Gupta
Journal:  Oncotarget       Date:  2015-04-20

5.  The small molecule ISRIB reverses the effects of eIF2α phosphorylation on translation and stress granule assembly.

Authors:  Carmela Sidrauski; Anna M McGeachy; Nicholas T Ingolia; Peter Walter
Journal:  Elife       Date:  2015-02-26       Impact factor: 8.140

6.  nanoCAGE reveals 5' UTR features that define specific modes of translation of functionally related MTOR-sensitive mRNAs.

Authors:  Valentina Gandin; Laia Masvidal; Laura Hulea; Simon-Pierre Gravel; Marie Cargnello; Shannon McLaughlan; Yutian Cai; Preetika Balanathan; Masahiro Morita; Arjuna Rajakumar; Luc Furic; Michael Pollak; John A Porco; Julie St-Pierre; Jerry Pelletier; Ola Larsson; Ivan Topisirovic
Journal:  Genome Res       Date:  2016-03-16       Impact factor: 9.043

7.  Translation reprogramming is an evolutionarily conserved driver of phenotypic plasticity and therapeutic resistance in melanoma.

Authors:  Paola Falletta; Luis Sanchez-Del-Campo; Jagat Chauhan; Maike Effern; Amy Kenyon; Christopher J Kershaw; Robert Siddaway; Richard Lisle; Rasmus Freter; Matthew J Daniels; Xin Lu; Thomas Tüting; Mark Middleton; Francesca M Buffa; Anne E Willis; Graham Pavitt; Ze'ev A Ronai; Tatjana Sauka-Spengler; Michael Hölzel; Colin R Goding
Journal:  Genes Dev       Date:  2017-01-17       Impact factor: 11.361

8.  Key contribution of eIF4H-mediated translational control in tumor promotion.

Authors:  Charlotte Vaysse; Céline Philippe; Yvan Martineau; Cathy Quelen; Corinne Hieblot; Claire Renaud; Yvan Nicaise; Aurore Desquesnes; Maria Pannese; Thomas Filleron; Ghislaine Escourrou; Malcolm Lawson; Robert C Rintoul; Marie Bernadette Delisle; Stéphane Pyronnet; Pierre Brousset; Hervé Prats; Christian Touriol
Journal:  Oncotarget       Date:  2015-11-24

9.  Cap-independent translation by DAP5 controls cell fate decisions in human embryonic stem cells.

Authors:  Yael Yoffe; Maya David; Rinat Kalaora; Lital Povodovski; Gilgi Friedlander; Ester Feldmesser; Elena Ainbinder; Ann Saada; Shani Bialik; Adi Kimchi
Journal:  Genes Dev       Date:  2016-09-01       Impact factor: 11.361

10.  eIF3d is an mRNA cap-binding protein that is required for specialized translation initiation.

Authors:  Amy S Lee; Philip J Kranzusch; Jennifer A Doudna; Jamie H D Cate
Journal:  Nature       Date:  2016-07-27       Impact factor: 49.962

View more
  19 in total

Review 1.  Translational Control in Cancer.

Authors:  Nathaniel Robichaud; Nahum Sonenberg; Davide Ruggero; Robert J Schneider
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-07-01       Impact factor: 10.005

2.  Estrogen receptor α promotes protein synthesis by fine-tuning the expression of the eukaryotic translation initiation factor 3 subunit f (eIF3f).

Authors:  Rafael Cuesta; Adi Y Berman; Anya Alayev; Marina K Holz
Journal:  J Biol Chem       Date:  2018-12-20       Impact factor: 5.157

3.  A novel function for the mitotic checkpoint protein Mad2p in translation.

Authors:  Sophie Gay
Journal:  Mol Cell Oncol       Date:  2018-08-06

4.  Single-Cell Lymphocyte Heterogeneity in Advanced Cutaneous T-cell Lymphoma Skin Tumors.

Authors:  Alyxzandria M Gaydosik; Tracy Tabib; Larisa J Geskin; Claire-Audrey Bayan; James F Conway; Robert Lafyatis; Patrizia Fuschiotti
Journal:  Clin Cancer Res       Date:  2019-04-22       Impact factor: 12.531

5.  Computational epigenetic landscape analysis reveals association of CACNA1G-AS1, F11-AS1, NNT-AS1, and MSC-AS1 lncRNAs in prostate cancer progression through aberrant methylation.

Authors:  Mahafujul Islam Quadery Tonmoy; Atqiya Fariha; Ithmam Hami; Kumkum Kar; Hasan Al Reza; Newaz Mohammed Bahadur; Md Shahadat Hossain
Journal:  Sci Rep       Date:  2022-06-17       Impact factor: 4.996

6.  Single-Cell RNA Sequencing Unveils the Clonal and Transcriptional Landscape of Cutaneous T-Cell Lymphomas.

Authors:  Alyxzandria M Gaydosik; Connor J Stonesifer; Alexandra E Khaleel; Larisa J Geskin; Patrizia Fuschiotti
Journal:  Clin Cancer Res       Date:  2022-06-13       Impact factor: 13.801

Review 7.  Translation acrobatics: how cancer cells exploit alternate modes of translational initiation.

Authors:  Ashwin Sriram; Jonathan Bohlen; Aurelio A Teleman
Journal:  EMBO Rep       Date:  2018-09-17       Impact factor: 8.807

Review 8.  A few good peptides: MHC class I-based cancer immunosurveillance and immunoevasion.

Authors:  Devin Dersh; Jaroslav Hollý; Jonathan W Yewdell
Journal:  Nat Rev Immunol       Date:  2020-08-20       Impact factor: 53.106

Review 9.  Translation initiation and its relevance in colorectal cancer.

Authors:  Emma Minnee; William James Faller
Journal:  FEBS J       Date:  2021-01-24       Impact factor: 5.622

Review 10.  Role of RONS and eIFs in Cancer Progression.

Authors:  Yasmeen Ahmed Salaheldin; Salma Sayed Mohamed Mahmoud; Ebenezeri Erasto Ngowi; Vivian Aku Gbordzor; Tao Li; Dong-Dong Wu; Xin-Ying Ji
Journal:  Oxid Med Cell Longev       Date:  2021-07-05       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.